Doctor profile · Federal record

Dr. Tapan Patel, M.D.

Nephrology Physician (CMS: Nephrology) · Dallas, TX

  • NPI 1942402227
  • Accepts Medicare
  • 23 yrs in practice
  • Male
  • Group practice
  • No sanctions

Practice & contact

NPPES Updated May 11, 2026
Primary practice
13154 Coit RD, Suite 100
Dallas, TX 752405773
(214) 366-6400
fax (214) 579-6989
Mailing address
1505 Lbj Fwy Ste 700
Dallas, TX 752346065

Credentials & registration

NPPES · NUCC
NPI registered
May 2007 — 19 yrs on file
Profile last updated
February 1, 2024
Year of graduation
2003 — 23 yrs since
Specialty taxonomy
207RN0300X — NUCC code
State license (1)
Texas #N3978

Federal sanctions & exclusions

OIG LEIE Updated May 11, 2026

No sanctions, exclusions or revocations on file

Checked against OIG LEIE on NPI 1942402227. Last verified May 11, 2026.

Medicare procedures · 2023

Top services delivered

CMS Provider Utilization
Total services
320
Distinct HCPCS
4
Medicare allowed
$30,684
HCPCS Description Services Patients Avg allowed
99214 Established patient office or other outpatient visit, 30-39 minutes 153 80 $87
99232 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes 86 52 $78
99233 Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes 61 38 $118
99223 Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes 20 20 $171

In context: peer comparison

Among 53 peers in Dallas Nephrology Physician, average services per provider: 162. This provider delivers 2.0× the peer median.

Open Payments

Industry payments received

CMS Open Payments
All-time total
$652
Transactions
27
Manufacturers
15
Payer (manufacturer) Industry Txns Amount
Alexion Pharmaceuticals, INC. 3 $95.62
Amgen INC. 3 $74.52
Aurinia Pharma U.S., INC. 3 $65.06
Boehringer Ingelheim Pharmaceuticals, INC. 3 $64.67
Fresenius USA Marketing, INC. 2 $44.39
AstraZeneca Pharmaceuticals Lp 2 $40.95
Novartis Pharmaceuticals Corporation 1 $29.10
Bayer Healthcare Pharmaceuticals INC. 2 $28.71
Otsuka Pharmaceutical Development & Commercialization, INC. 1 $28.54
Ani Pharmaceuticals, INC. 1 $28.15
GlaxoSmithKline, LLC. 2 $27.94
Gilead Sciences, INC. 1 $27.51
Alnylam Pharmaceuticals INC. 1 $23.51
Otsuka America Pharmaceutical, INC. 1 $20.85
Recor Medical INC 1 $19.73

By nature of payment

Food and Beverage
$652

Medicare Part D · 2023

Top prescriptions

CMS Part D Prescriber
Total claims
222
Patients
43
Total drug cost
$79,421
Drug Type Claims Patients Total cost
Amlodipine Besylate Generic 55 18 $435
Losartan Potassium Generic 43 14 $743
Furosemide Generic 31 11 $147
Hydralazine Hcl Generic 13 0 $105
Auryxia (Ferric Citrate) Brand 12 0 $28,348
Carvedilol Generic 12 0 $308
Hydrochlorothiazide Generic 12 0 $101
Sevelamer Carbonate Generic 11 0 $6,848
Tolvaptan Generic 11 0 $41,814
Torsemide Generic 11 0 $390

Hospital affiliations

CMS Hospital Compare

Frequently asked questions

Auto-generated from federal data
What is Dr. Tapan Patel's medical specialty?
Dr. Tapan Patel practices Nephrology Physician in Dallas, TX.
Where does Dr. Tapan Patel practice?
Dr. Tapan Patel practices at 13154 Coit RD, Dallas, TX 752405773. Office phone: 2143666400.
What is Dr. Tapan Patel's NPI?
Dr. Tapan Patel's National Provider Identifier (NPI) is 1942402227, issued by NPPES.
Does Dr. Tapan Patel accept Medicare assignment?
Yes. Dr. Tapan Patel accepts Medicare assignment, meaning Medicare-allowed amounts are accepted as full payment for covered services.
What procedures does Dr. Tapan Patel commonly perform?
Top Medicare-reported procedures in 2023: Established patient office or other outpatient visit (HCPCS 99214); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99232); Subsequent hospital care with moderate levelof medical decision making (HCPCS 99233). Source: CMS Medicare Physician & Other Practitioners file.